Zephyrm Biotech
Beijing
About Zephyrm Biotech
Zephyrm Biotech develops stem cell therapeutics and promotes stem cell clinical use and industrial transformation, allowing clients to address needs that normal medicines and treatment methods cannot.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $29.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2023)
- Website: zephyrm.com
- Phone: 010-5939 3118
Industries & Categories
Biotechnology, Medical
Canonical: https://fsome.com/organization/zephyrm-biotech-48253 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.